140 related articles for article (PubMed ID: 1848576)
21. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
22. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
Caldeira S; de Villiers EM; Tommasino M
Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
[TBL] [Abstract][Full Text] [Related]
24. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
Liu Z; Ghai J; Ostrow RS; Faras AJ
Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
[TBL] [Abstract][Full Text] [Related]
25. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
26. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
27. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
Banks L; Edmonds C; Vousden KH
Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
[TBL] [Abstract][Full Text] [Related]
28. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
Brokaw JL; Yee CL; Münger K
Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
[TBL] [Abstract][Full Text] [Related]
29. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Pim D; Storey A; Thomas M; Massimi P; Banks L
Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
[TBL] [Abstract][Full Text] [Related]
32. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
[TBL] [Abstract][Full Text] [Related]
33. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
Vousden KH; Doniger J; DiPaolo JA; Lowy DR
Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
[TBL] [Abstract][Full Text] [Related]
34. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
35. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
Jones DL; Thompson DA; Münger K
Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450
[TBL] [Abstract][Full Text] [Related]
36. Improved immunodetection of human papillomavirus E7.
Jeon JH; Cho SY; Kim CW; Shin DM; Kwon JC; Choi KH; Kim IG
Exp Mol Med; 2002 Dec; 34(6):496-9. PubMed ID: 12526093
[TBL] [Abstract][Full Text] [Related]
37. Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells.
Routes JM; Ryan S
J Virol; 1995 Dec; 69(12):7639-47. PubMed ID: 7494272
[TBL] [Abstract][Full Text] [Related]
38. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.
Sang BC; Barbosa MS
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8063-7. PubMed ID: 1325643
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]